Twice‐daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice‐daily omeprazole, rabeprazole or lansoprazole

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|38|9|1129-1137

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.38, Iss.9, 2013-11, pp. : 1129-1137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Twice‐daily pill could treat leukemia

By  

CANCER, Vol. 120, Iss. 15, 2014-08 ,pp. : 2225-2225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice‐daily dosing: a single‐center prospective study with historical control

By  

TRANSFUSION, Vol. 55, Iss. 8, 2015-08 ,pp. : 2032-2038

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment satisfaction with ITCA 650, a novel drug‐device delivering continuous exenatide, versus twice‐daily injections of exenatide in type 2 diabetics using metformin

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 638-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma

By Knox A   Langan J   Martinot J-B   Gruss C   Häfner D  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2387-2394

Informa Healthcare

Access to resources Recommend Favorite

Conversion from twice‐daily to once‐daily tacrolimus formulation in pediatric liver transplant recipients – a long‐term prospective study

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 31, Iss. 1, 2018-01 ,pp. : 38-44

John Wiley & Sons Inc

Access to resources Recommend Favorite